Allink Biotherapeutics

Shanghai Allink Biotherapeutics Co., Ltd.

Shanghai, China · Founded 2023 · $89.0M raised

Headquarters
Shanghai
Employees
11–50
Founded
2023
Business Model
B2B
Total Funding
$89.0M
Last Round
$47.0M Extension RoundDec 2025
Rounds
2

About

Allink Biotherapeutics is a Shanghai biotechnology company developing precision-medicine treatments based on antibody-drug conjugates and bispecific antibodies. Its proprietary platforms support antibody screening and the development of differentiated ADC candidates, including programs that have advanced to global Phase I trials. The company says its pipeline combines clinical-stage assets with earlier programs intended to address serious diseases through targeted therapeutics.

Summary

Allink Biotherapeutics is a Biotech company based in Shanghai, China, founded in 2023. It has raised $89.0M in total across 2 rounds, most recently a $47.0M Extension Round round in Dec 2025. Investors include Legend Capital, Lanchi Ventures and Meituan Long-Z.

Tech & App Stack

Funding History

Extension RoundSeries A ExtensionDec 2025
$47.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Allink Biotherapeutics on Indexed.vc
<a href="https://indexed.vc/companies/allink-biotherapeutics"><img src="https://indexed.vc/api/badge/company/allink-biotherapeutics" alt="Allink Biotherapeutics on Indexed.vc" width="260" height="76" /></a>